The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Shares of CVS Health Corp. CVS rose 1.67% to $67.46 Friday, on what proved to be an all-around poor trading session for the ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

Helius Medical Technologies (HSDT) stock surged on Wednesday after the neurotech company announced an authorized claim for payment for its Portable Neuromodulation Stimulator (PoNS) from CVS Health ...

Elevance Health reported a benefit expense ratio of 86.4% in the first quarter, up 80 bps year over year, mainly because Medicaid rates failed to keep up with medical cost trends. High-cost trends ...

Alpha Omega Wealth Management made a bold move by boosting its stake in CVS Health by 23% in Q1, now holding 148,919 shares ...

UnitedHealth Group (UNH) concluded the recent trading session at $310.56, signifying a +2.23% move from its prior day's close.

Here is how Adaptive Biotechnologies (ADPT) and CVS Health (CVS) have performed compared to their sector so far this year.

KMG Fiduciary Partners LLC dramatically reduced its investment in CVS Health, selling off 88.1% of its shares. The investor ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...